156 related articles for article (PubMed ID: 32102131)
1. Expression of Chemokine CCL28 in Ulcerative Colitis Patients.
Lee DS; Lee KL; Jeong JB; Shin S; Kim SH; Kim JW
Gut Liver; 2021 Jan; 15(1):70-76. PubMed ID: 32102131
[TBL] [Abstract][Full Text] [Related]
2. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.
Manousou P; Kolios G; Valatas V; Drygiannakis I; Bourikas L; Pyrovolaki K; Koutroubakis I; Papadaki HA; Kouroumalis E
Clin Exp Immunol; 2010 Nov; 162(2):337-47. PubMed ID: 21077277
[TBL] [Abstract][Full Text] [Related]
4. Increased serum levels of eotaxin in patients with inflammatory bowel disease.
Chen W; Paulus B; Shu D; Wilson ; Chadwick V
Scand J Gastroenterol; 2001 May; 36(5):515-20. PubMed ID: 11346206
[TBL] [Abstract][Full Text] [Related]
5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
6. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment.
Lee HJ; Choi SC; Lee MH; Oh HM; Choi EY; Choi EJ; Yun KJ; Seo GS; Kim SW; Lee JG; Han WC; Park KI; Jun CD
Inflamm Bowel Dis; 2005 Dec; 11(12):1070-9. PubMed ID: 16306769
[TBL] [Abstract][Full Text] [Related]
8. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
9. Colonic mucosa-associated candida assessed by biopsy culture is associated with disease severity in ulcerative colitis: A prospective study.
Shah J; Dutta U; Rudramurthy S; Chakrabarti A; Sinha SK; Sharma V; Mandavdhare H; Sharma P; Kalsi D; Popli P; Radhika S; Das A; Kochhar R
J Dig Dis; 2019 Dec; 20(12):642-648. PubMed ID: 31626384
[TBL] [Abstract][Full Text] [Related]
10. The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.
Lakatos G; Sipos F; Miheller P; Hritz I; Varga MZ; Juhász M; Molnár B; Tulassay Z; Herszényi L
Pathol Oncol Res; 2012 Jan; 18(1):85-91. PubMed ID: 21678108
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
12. Serum mucosa-associated epithelial chemokine in atopic dermatitis: a specific marker for severity.
Ezzat MH; Shaheen KY
Indian J Dermatol; 2009 Jul; 54(3):229-36. PubMed ID: 20161852
[TBL] [Abstract][Full Text] [Related]
13. Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.
Piekkala M; Hagström J; Tanskanen M; Rintala R; Haglund C; Kolho KL
World J Gastroenterol; 2013 Jun; 19(21):3272-80. PubMed ID: 23745029
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis.
Jodeleit H; Milchram L; Soldo R; Beikircher G; Schönthaler S; Al-Amodi O; Wolf E; Beigel F; Weinhäusel A; Siebeck M; Gropp R
PLoS One; 2020; 15(2):e0228615. PubMed ID: 32050001
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.
Soendergaard C; Nielsen OH; Seidelin JB; Kvist PH; Bjerrum JT
Inflamm Bowel Dis; 2015 May; 21(5):1077-88. PubMed ID: 25803506
[TBL] [Abstract][Full Text] [Related]
16. Absence of salivary CCL28 in primary Sjögren's syndrome.
Hernandez-Molina G; Burkhardt AM; Lima G; Zlotnik A; Betanzos JL; Bahena S; Llorente L
Rheumatol Int; 2015 Aug; 35(8):1431-4. PubMed ID: 25567740
[TBL] [Abstract][Full Text] [Related]
17. High serum vaspin concentrations in patients with ulcerative colitis.
Morisaki T; Takeshima F; Fukuda H; Matsushima K; Akazawa Y; Yamaguchi N; Ohnita K; Isomoto H; Takeshita H; Sawai T; Fujita F; Nakao K
Dig Dis Sci; 2014 Feb; 59(2):315-21. PubMed ID: 24166663
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Infection in Ulcerative Colitis is Related to Severe Inflammation and a High Count of Cytomegalovirus-positive Cells in Biopsy Is a Risk Factor for Colectomy.
Zagórowicz E; Bugajski M; Wieszczy P; Pietrzak A; Magdziak A; Mróz A
J Crohns Colitis; 2016 Oct; 10(10):1205-11. PubMed ID: 26971053
[TBL] [Abstract][Full Text] [Related]
19. The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids.
Yang SK; Choi MS; Kim OH; Myung SJ; Jung HY; Hong WS; Kim JH; Min YI
Am J Gastroenterol; 2002 Jan; 97(1):126-32. PubMed ID: 11808935
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]